Is it safe to take Myra Glow Radiance White (containing L‑glutathione, vitamin C, grapeseed extract, and vitamin E) while using tirzepatide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Safety of Myra Glow Radiance White with Tirzepatide

There is no documented drug interaction between the components of Myra Glow Radiance White (L-glutathione, vitamin C, grapeseed extract, vitamin E) and tirzepatide, and these supplements can generally be taken together safely. However, critical safety considerations exist, particularly regarding glutathione formulation and your nutritional status while on tirzepatide.

Key Safety Considerations

Glutathione Formulation Matters Critically

The safety profile depends entirely on how you're taking glutathione:

  • Oral glutathione supplements (like Myra Glow): Generally safe with minimal side effects 1
  • Intravenous glutathione: Absolutely contraindicated - particularly dangerous in patients on tirzepatide with reduced nutritional intake 2

A recent 2025 case report documented life-threatening systemic inflammatory response syndrome (SIRS) in a patient taking tirzepatide who received high-dose IV glutathione 2. The patient developed shock, fever >41°C, severe liver injury, and coagulopathy requiring intensive care. The mechanism likely involved either endotoxin contamination of unregulated IV products or a synergistic toxic effect in a nutritionally compromised state.

Tirzepatide-Specific Concerns

While taking tirzepatide, you need to be aware of:

Reduced nutritional intake: Tirzepatide causes significant appetite suppression and gastrointestinal effects (nausea in 25% of patients, vomiting/diarrhea in up to 10%) 3, 4. This creates a nutritionally compromised state that may alter how your body handles high-dose antioxidants.

Gastrointestinal side effects: The most common adverse effects are GI-related, occurring especially during dose escalation 4. Adding supplements should be done cautiously to avoid exacerbating nausea or GI distress.

Dehydration risk: Patients with vomiting or diarrhea from tirzepatide should be monitored for dehydration and renal impairment 4. Adequate hydration is essential when taking any supplements.

Practical Recommendations

Safe Use Guidelines

  • Use oral formulations only - never IV glutathione products, especially unregulated ones
  • Maintain adequate nutrition despite appetite suppression from tirzepatide
  • Stay well-hydrated - drink plenty of water throughout the day
  • Take supplements with small meals to minimize GI upset
  • Start tirzepatide at the lowest dose (2.5 mg weekly) and titrate slowly 4

Warning Signs to Monitor

Stop supplements and contact your healthcare provider if you develop:

  • Severe abdominal pain (with or without nausea/vomiting) - could indicate pancreatitis or gallbladder disease 3
  • Fever, chills, or signs of systemic illness
  • Significant worsening of GI symptoms
  • Signs of dehydration (decreased urination, dizziness, dry mouth)

Evidence Quality Note

No direct drug interaction studies exist between these specific supplements and tirzepatide. The safety concern stems from a single but serious case report 2 involving IV glutathione in a tirzepatide-treated patient. The oral formulation in Myra Glow has a different safety profile than IV preparations, with studies showing oral glutathione is generally well-tolerated 1, 5.

Bottom Line

Oral Myra Glow Radiance White can be taken with tirzepatide, but maintain adequate nutrition, stay hydrated, and never use IV glutathione products. The antioxidant vitamins (C and E) and grapeseed extract have no known interactions with tirzepatide. The key is ensuring you're not in a nutritionally depleted state from tirzepatide's appetite-suppressing effects when taking these supplements.

Related Questions

Can an IV glutathione solution be administered if it has been opened for more than six hours?
What management steps should be taken for a 33-year-old woman with type 2 diabetes mellitus, BMI >34 kg/m², currently on glimepiride, metformin, empagliflozin, and tirzepatide (Mounjaro) titrated to 7.5 mg who continues to have excessive hunger and no weight loss despite stable glycemia?
In a healthy adult with no known allergies or cardiovascular, respiratory, or neurological problems, can I play tennis after a glutathione intravenous (IV) drip?
Can tirzepatide be combined with Jardiance Duo (empagliflozin and metformin) in adults with type 2 diabetes?
Does intravenous glutathione improve melasma?
When should lung re‑expansion be assessed after chest tube placement and initiation of anti‑tuberculosis therapy—approximately 7‑10 days or after the intensive phase?
Can a patient experience diarrhea following a transrectal prostate biopsy?
Should lamotrigine and sertraline be continued during general intravenous anesthesia, and what interactions or precautions should be considered?
Does guaifenesin relieve muscle and joint stiffness?
What are the possible causes of pancytopenia in a patient with a normal mean corpuscular volume (MCV) and a peripheral blood smear showing target cells and normal‑appearing segmented neutrophils?
What NSAID and dosage should be prescribed for a patient with renal colic who has normal renal function, no active peptic ulcer disease, and is not on anticoagulants?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.